Gene-Disorder Association · Article
Gene
VWF Von Willebrand Factor
×
First reported
1950
Supporting publications
13
Approved treatment annotated
Association Review
In brief The association between VWF (Von Willebrand Factor) and Thrombocytopenia is supported by expert-curated evidence, drawing on a single expert-curated source, which records likely-pathogenic variants.
Sources
1
Clinical variants
16
Symptoms
0
Compounds
2
Trials
4 of 2,137 via VWF compounds
Publications
13
Contents
01
At a glance
Association overview A cited synthesis of the gene–disorder association, with a clinical-actionability summary where the evidence supports one.
Request access
02
Provenance
Evidence and sources 1 source
Every contributing database and publication behind this association, with evidence type, strength, accessions and deep links.
Request access
1 source summary
A gene summary alongside the source descriptions it was distilled from.
Request access
04
Thrombocytopenia
The disorder 7 database identifiers
The disorder’s summary, prevalence, aliases and cross-reference identifiers (OMIM, Orphanet, MONDO, ICD-10, MedGen).
Request access
05
ClinVar and variant evidence
Genetic basis 16 clinical variants
ClinVar variants reported for this pair, with disorder-specific significance, review status, molecular consequence and origin.
Request access
06
Interventions
Therapeutics 2 compounds & drugs
Gene-targeting drugs and associated compounds, with class, approval status, mechanism, indications and trials.
Request access
07
Human studies
Clinical trials 2,137 clinical trials
Clinical trials reached through the pair’s compounds, keeping disorder-targeting trials separate from other indications.
Request access
13 publications
Publications linking the gene and the disorder, with title, authors, journal, year and citation metrics.
Request access
09
Provenance
References & sources 12 references
Every source and publication cited across this dossier, as one numbered reference list.
Request access